Target intelligence / Profile preview

Fat intake

01

Overview

Fat intake refers to the physiological process of consuming and absorbing dietary lipids, which serve as a critical energy source and structural component for cell membranes. It is not a single molecular target such as a receptor or enzyme, but rather a behavioral and metabolic process regulated by a complex network involving central nervous system signaling, gastrointestinal hormones, and peripheral metabolism. Pharmacological interventions related to fat intake typically target specific molecular components like gastric and pancreatic lipases to prevent lipid breakdown, or act on central receptors to modulate appetite and satiety. Chronic excessive fat intake is strongly associated with the pathophysiology of obesity, cardiovascular disease, and metabolic syndrome, making the regulation of this process a primary focus for therapeutic research. While not a standalone target, the pathways governing fat intake involve well-characterized molecules such as the melanocortin 4 receptor (MC4R) and the glucagon-like peptide 1 receptor (GLP-1R) (NIH, 2021; StatPearls, 2023).

Other names
Dietary fat consumptionLipid intakeDietary lipid ingestionHigh-fat diet (HFD) consumption
02

Mechanism of action

Drugs modulate the outcome of fat intake by inhibiting digestive enzymes (e.g., pancreatic lipase) to prevent systemic absorption, or by activating hypothalamic signaling pathways (e.g., GLP-1 or MC4 receptors) to reduce appetite and the reward-driven consumption of calorie-dense foods.

03

Biological functions

Energy homeostasisLipid metabolismNutrient sensingSatiety signalingThermogenesis
04

Disease associations

ObesityMetabolic syndromeHyperlipidemiaType 2 diabetesNonalcoholic fatty liver disease (NAFLD)Cardiovascular disease
05

Safety considerations

Gastrointestinal side effects (e.g., steatorrhea, oily spotting)Malabsorption of fat-soluble vitamins (A, D, E, K)Compensatory overeating due to psychological factorsGastrointestinal motility issuesNausea and vomiting
06

Interacting drugs

Orlistat

4 more in the full profile.

07

Biomarkers

Body Mass Index (BMI)Waist circumferenceSerum triglyceridesPlasma leptin levelsAdiponectin levelsFecal fat excretion

Beyond the preview

Go deeper on Fat intake.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fat intake.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call